SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19Nina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Cochrane Database of Systematic Reviews|2021Cited by 152
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19Nina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Cochrane Database of Systematic Reviews|2021Cited by 68
Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic reviewVanessa Piechotta, Nicole Skoetz, Sibylle C. Mellinghoff et al.|Blood Cancer Journal|2022Cited by 43
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19Caroline Hirsch, Nina Kreuzberger, Miriam Stegemann et al.|Cochrane Database of Systematic Reviews|2022Cited by 41
Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping reviewNina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Cochrane Database of Systematic Reviews|2022Cited by 22